Dementia-like pathology in type-2 diabetes: A novel microRNA mechanism

Molecular and Cellular Neuroscience

Volumn 80, Issue , 2017, Pages 58-65

  Kalani, Anuradha ^a   Chaturvedi, Pankaj ^a   Maldonado, Claudio ^a   Bauer, Philip ^a   Joshua, Irving G ^a   Tyagi, Suresh C ^a   Tyagi, Neetu ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cellular prion protein; Dementia; Diabetes; Memory; microRNA

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; MICRORNA; MICRORNA 146A; PRION PROTEIN; ENDOTHELIAL CELL GROWTH FACTOR; LEPTIN RECEPTOR; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; MIRN146 MICRORNA, MOUSE; TAU PROTEIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN ENDOTHELIUM CELL DERIVED EXOSOME; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DOWN REGULATION; EXOSOME; GENE EXPRESSION; GENETIC TRANSCRIPTION; MALE; MICROTUBULE ORGANIZING CENTER; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PATHOLOGY; PHOSPHORYLATION; PRION PROTEIN GENE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SHORT TERM MEMORY; UPREGULATION; Y-MAZE TEST; ANIMAL; C57BL MOUSE; COMPLICATION; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; MAZE TEST; METABOLISM; PHYSIOLOGY; RECOGNITION;

ANIMALS; BRAIN; DEMENTIA; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MICROTUBULE-ASSOCIATED PROTEINS; PRION PROTEINS; RECEPTORS, LEPTIN; RECOGNITION (PSYCHOLOGY); RNA, MESSENGER; TAU PROTEINS;

EID: 85014172370     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2017.02.005     Document Type: Article

References (36)

1. Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., Wood, M.J., Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29 (2011), 341–345.
2. Arvanitakis, Z., Schneider, J.A., Wilson, R.S., Li, Y., Arnold, S.E., Wang, Z., Bennett, D.A., Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 67 (2006), 1960–1965.
3. Bellingham, S.A., Coleman, B.M., Hill, A.F., Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res. 40 (2012), 10937–10949.
4. Chung, E., Ji, Y., Sun, Y., Kascsak, R.J., Kascsak, R.B., Mehta, P.D., Strittmatter, S.M., Wisniewski, T., Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. BMC Neurosci., 11, 2010, 130.
5. Davis, W.A., Zilkens, R.R., Starkstein, S.E., Davis, T.M., Bruce, D.G., Dementia onset, incidence and risk in type 2 diabetes: a matched cohort study with the Fremantle Diabetes Study Phase I. Diabetologia, 2016.
6. Ferri, C.P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., Jorm, A., Mathers, C., Menezes, P.R., Rimmer, E., Scazufca, M., Alzheimer's Disease, I., Global prevalence of dementia: a Delphi consensus study. Lancet 366 (2005), 2112–2117.
7. Gimbel, D.A., Nygaard, H.B., Coffey, E.E., Gunther, E.C., Lauren, J., Gimbel, Z.A., Strittmatter, S.M., Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J. Neurosci. 30 (2010), 6367–6374.
8. Gispen, W.H., Biessels, G.J., Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 23 (2000), 542–549.
9. Gudala, K., Bansal, D., Schifano, F., Bhansali, A., Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J. Diabetes Investig. 4 (2013), 640–650.
10. Haan, M.N., Mungas, D.M., Gonzalez, H.M., Ortiz, T.A., Acharya, A., Jagust, W.J., Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. J. Am. Geriatr. Soc. 51 (2003), 169–177.
11. Haney, M.J., Klyachko, N.L., Zhao, Y., Gupta, R., Plotnikova, E.G., He, Z., Patel, T., Piroyan, A., Sokolsky, M., Kabanov, A.V., Batrakova, E.V., Exosomes as drug delivery vehicles for Parkinson's disease therapy. J. Control. Release 207 (2015), 18–30.
12. Ivask, M., Hugill, A., Koks, S., RNA-sequencing of WFS1-deficient pancreatic islets. Phys. Rep., 4, 2016.
13. Janson, J., Laedtke, T., Parisi, J.E., O'Brien, P., Petersen, R.C., Butler, P.C., Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53 (2004), 474–481.
14. Kalani, A., Kamat, P.K., Chaturvedi, P., Tyagi, S.C., Tyagi, N., Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia. Life Sci. 107 (2014), 1–7.
15. Kalani, A., Kamat, P.K., Familtseva, A., Chaturvedi, P., Muradashvili, N., Narayanan, N., Tyagi, S.C., Tyagi, N., Role of microRNA29b in blood-brain barrier dysfunction during hyperhomocysteinemia: an epigenetic mechanism. J. Cereb. Blood Flow Metab. 34 (2014), 1212–1222.
16. Kalani, A., Tyagi, A., Tyagi, N., Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics. Mol. Neurobiol. 49 (2014), 590–600.
17. Kalani, A., Chaturvedi, P., Kamat, P.K., Maldonado, C., Bauer, P., Joshua, I.G., Tyagi, S.C., Tyagi, N., Curcumin-loaded embryonic stem cell exosomes restored neurovascular unit following ischemia-reperfusion injury. Int. J. Biochem. Cell Biol. 79 (2016), 360–369.
18. Kantharidis, P., Wang, B., Carew, R.M., Lan, H.Y., Diabetes complications: the microRNA perspective. Diabetes 60 (2011), 1832–1837.
19. Maes, O.C., Chertkow, H.M., Wang, E., Schipper, H.M., MicroRNA: implications for Alzheimer disease and other human CNS disorders. Curr. Genomics 10 (2009), 154–168.
20. Marcus, M.E., Leonard, J.N., FedExosomes: engineering therapeutic biological nanoparticles that truly deliver. Pharmaceuticals 6 (2013), 659–680.
21. Muradashvili, N., Tyagi, R., Metreveli, N., Tyagi, S.C., Lominadze, D., Ablation of MMP9 gene ameliorates paracellular permeability and fibrinogen-amyloid beta complex formation during hyperhomocysteinemia. J. Cereb. Blood Flow Metab. 34 (2014), 1472–1482.
22. Muradashvili, N., Benton, R.L., Saatman, K.E., Tyagi, S.C., Lominadze, D., Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice. Metab Brain Dis. 30 (2015), 411–426.
23. Nisbet, R.M., Polanco, J.C., Ittner, L.M., Gotz, J., Tau aggregation and its interplay with amyloid-beta. Acta Neuropathol. 129 (2015), 207–220.
24. Noormets, K., Koks, S., Muldmaa, M., Mauring, L., Vasar, E., Tillmann, V., Sex differences in the development of diabetes in mice with deleted wolframin (Wfs1) gene. Exp. Clin. Endocrinol. Diabetes 119 (2011), 271–275.
25. Peila, R., Rodriguez, B.L., Launer, L.J., Honolulu-Asia Aging, S., Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia aging study. Diabetes 51 (2002), 1256–1262.
26. Pendlebury, S.T., Rothwell, P.M., Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 8 (2009), 1006–1018.
27. Poy, M.N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., Macdonald, P.E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., Stoffel, M., A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432 (2004), 226–230.
28. Ramos-Rodriguez, J.J., Ortiz, O., Jimenez-Palomares, M., Kay, K.R., Berrocoso, E., Murillo-Carretero, M.I., Perdomo, G., Spires-Jones, T., Cozar-Castellano, I., Lechuga-Sancho, A.M., Garcia-Alloza, M., Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice. Psychoneuroendocrinology 38 (2013), 2462–2475.
29. Reitz, C., Brayne, C., Mayeux, R., Epidemiology of Alzheimer disease. Nat. Rev. Neurol. 7 (2011), 137–152.
30. Ritchie, K., Lovestone, S., The dementias. Lancet 360 (2002), 1759–1766.
31. Saedi, E., Gheini, M.R., Faiz, F., Arami, M.A., Diabetes mellitus and cognitive impairments. World J. Diabetes 7 (2016), 412–422.
32. Sokolova, V., Ludwig, A.K., Hornung, S., Rotan, O., Horn, P.A., Epple, M., Giebel, B., Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf. B Biointerfaces 87 (2011), 146–150.
33. Takashima, A., Honda, T., Yasutake, K., Michel, G., Murayama, O., Murayama, M., Ishiguro, K., Yamaguchi, H., Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25–35) enhances phosphorylation of tau in hippocampal neurons. Neurosci. Res. 31 (1998), 317–323.
34. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J.J., Lotvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9 (2007), 654–659.
35. Wiesmann, M., Kiliaan, A.J., Claassen, J.A., Vascular aspects of cognitive impairment and dementia. J. Cereb. Blood Flow Metab. 33 (2013), 1696–1706.
36. Zomer, A., Vendrig, T., Hopmans, E.S., van Eijndhoven, M., Middeldorp, J.M., Pegtel, D.M., Exosomes: fit to deliver small RNA. Commun. Integr. Biol. 3 (2010), 447–450.